BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
9/21/18 GTx (GTXI) Enobosarm for Urinary Incontinence Subscribers Only Subscribers Only Subscribers Only
9/21/18 Sarepta (SRPT) Exondys 51 for Duchenne Muscular Dystrophy (DMD) Subscribers Only Subscribers Only Subscribers Only
9/20/18 Acadia (ACAD) Nuplazid for Parkinson's Disease (PD) Subscribers Only Subscribers Only Subscribers Only
9/20/18 Novo Nordisk (NVO) Oral Semaglutide for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
9/20/18 Galectin Therapeutics (GALT) GR-MD-02 for Melanoma Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
09/22/18 Subscribers Only Subscribers Only Trial Data - Final Results
09/22/18 Subscribers Only Subscribers Only Trial Data (Emerging Markets)
09/22/18 Subscribers Only Subscribers Only Trial Data - Updated Results
09/22/18 Subscribers Only Subscribers Only Trial Data - Other
Now - 09/24/18 Subscribers Only Subscribers Only Trial Data - Updated Results
Back to the top Back to the top